IPHA
Innate Pharma
IPHA
IPHA
6 hedge funds and large institutions have $6.36M invested in Innate Pharma in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.1K |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.43M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$2.62M |
| 3 |
Morgan Stanley
New York
|
-$41.5K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Wellington Management Group
Boston,
Massachusetts
| $5.39M | +$20.1K | +5,059 | +0.4% |
|
|
RCMNY
2
Rubric Capital Management (New York)
New York
| $960K | -$2.62M | -681,673 | -73% |
|
3
Osaic Holdings
Scottsdale,
Arizona
| $8K | – | – | – |
|
|
4
Morgan Stanley
New York
| $6K | -$41.5K | -10,870 | -87% |
|
|
SPIA
5
Steward Partners Investment Advisory
New York
| $4K | – | – | – |
|
6
Millennium Management
New York
| $288 | – | – | – |
|
|
7
Adage Capital Partners
Boston,
Massachusetts
| – | -$3.43M | -500,000 | Closed |
|